Compositions and methods for inhibiting expression of factor...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/113 (2010.01) A61K 31/713 (2006.01) C12N 9/64 (2006.01) C12N 15/11 (2006.01)

Patent

CA 2743249

The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a Factor VII gene. The invention also relates to a pharmaceutical composition comprising the dsRNA or nucleic acid molecules or vectors encoding the same together with a pharmaceutically acceptable carrier; methods for treating diseases caused by the expression of a Factor VII gene using said pharmaceutical composition; and methods for inhibiting the expression of Factor VII in a cell.

La présente invention concerne un acide ribonucléique double brin (ARNdb) permettant d'inhiber l'expression d'un gène du facteur VII. L'invention concerne également une composition pharmaceutique contenant l'ARNdb ou des molécules ou vecteurs d'acide nucléique codant pour celui-ci ainsi qu'un véhicule pharmaceutiquement acceptable ; des méthodes de traitement de maladies causées par l'expression d'un gène du facteur VII à l'aide de ladite composition pharmaceutique ; et des méthodes d'inhibition de l'expression du facteur VII dans une cellule.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compositions and methods for inhibiting expression of factor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for inhibiting expression of factor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for inhibiting expression of factor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2059829

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.